Your browser doesn't support javascript.
loading
Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.
Hu, Chunhong; Zhao, Lishu; Liu, Wenliang; Fan, Songqing; Liu, Junqi; Liu, Yuxuan; Liu, Xiaohan; Shu, Long; Liu, Xianling; Liu, Ping; Deng, Chao; Qiu, Zhenhua; Chen, Chen; Jiang, Yi; Liang, Qingchun; Yang, Lingling; Shao, Yang; He, Qiongzhi; Yu, Danlei; Zeng, Yue; Li, Yizheng; Pan, Yue; Zhang, Sujuan; Shi, Shenghao; Peng, Yurong; Wu, Fang.
Afiliação
  • Hu C; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Zhao L; Hunan Cancer Mega-Data Intelligent Application and Engineering Research Centre, Changsha, China.
  • Liu W; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Fan S; Department of Thoracic Surgery, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Liu J; Department of Pathology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Liu Y; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Liu X; Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China.
  • Shu L; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Liu X; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Liu P; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Deng C; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Qiu Z; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Chen C; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Jiang Y; Department of Thoracic Surgery, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Liang Q; Department of Pathology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Yang L; Department of Pathology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Shao Y; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc, Nanjing 210032, China.
  • He Q; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc, Nanjing 210032, China.
  • Yu D; Geneplus-Beijing Institute, Beijing, China.
  • Zeng Y; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Li Y; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Pan Y; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Zhang S; Department of Oncology, Central South University, Changsha, China.
  • Shi S; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Peng Y; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
  • Wu F; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
J Immunother Cancer ; 9(12)2021 12.
Article em En | MEDLINE | ID: mdl-34887263

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Linfócitos do Interstício Tumoral / Carcinoma Pulmonar de Células não Pequenas / Microambiente Tumoral / Antígeno B7-H1 / Mutação / Neoplasias Primárias Múltiplas Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Linfócitos do Interstício Tumoral / Carcinoma Pulmonar de Células não Pequenas / Microambiente Tumoral / Antígeno B7-H1 / Mutação / Neoplasias Primárias Múltiplas Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China